⌘K
Loading ticker…
As of 2026-08-25, Kewaunee Scientific Corp (KEQU) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.1%, relative volume 1.01×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
KEQU is held by 3 ETFs as of May 2026. Top owner: AVUV at 0.01% weight, $2M notional. Top 3 carry $2M.
Held by 15 ETFs · $7M across latest filings · largest weight 0.02% (IWC).
Top 3 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.01% | $2M | — |
| AVSC | 0.01% | $152K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $53K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KEQU Jan avg: 2.47% median: 3.69% win: 75% σ: 3.90% n: 4 2022-04-14 → 2026-07-31 | KEQU Feb avg: -4.12% median: -2.97% win: 50% σ: 9.23% n: 4 2022-04-14 → 2026-07-31 | KEQU Mar avg: -5.92% median: -8.21% win: 50% σ: 21.09% n: 4 2022-04-14 → 2026-07-31 | KEQU Apr avg: -0.84% median: 3.78% win: 60% σ: 11.09% n: 5 2022-04-14 → 2026-07-31 | KEQU May avg: 11.40% median: 9.62% win: 100% σ: 9.11% n: 5 2022-04-14 → 2026-07-31 | KEQU Jun avg: 10.81% median: 9.87% win: 60% σ: 25.94% n: 5 2022-04-14 → 2026-07-31 | KEQU Jul avg: 5.54% median: 3.37% win: 80% σ: 9.29% n: 5 2022-04-14 → 2026-07-31 | KEQU Aug avg: 1.07% median: 0.74% win: 50% σ: 4.21% n: 4 2022-04-14 → 2026-07-31 (current) | KEQU Sep avg: -15.58% median: -17.76% win: 25% σ: 21.05% n: 4 2022-04-14 → 2026-07-31 | KEQU Oct avg: -1.21% median: -2.96% win: 25% σ: 4.82% n: 4 2022-04-14 → 2026-07-31 | KEQU Nov avg: 3.69% median: -2.90% win: 25% σ: 19.02% n: 4 2022-04-14 → 2026-07-31 | KEQU Dec avg: 27.82% median: 24.39% win: 75% σ: 35.32% n: 4 2022-04-14 → 2026-07-31 |